Evidence map›Paper›PMID 39345227›Full record

ArticleElectrophoresis2024

Analytical Methods to Evaluate RNA Circularization Efficiency.

Yali Sun, Anis H Khimani, Yanhong Tong, Zhi-Xiang Lu

Abstract read
In one paragraph

Article in Electrophoresis, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Yali SunRevvity Health Sciences, Revvity, Inc., Waltham, Massachusetts, USA.ORCID 0000-0003-0293-1661
Anis H KhimaniRevvity Health Sciences, Revvity, Inc., Waltham, Massachusetts, USA.
Yanhong TongRevvity Health Sciences, Revvity, Inc., Waltham, Massachusetts, USA.ORCID 0009-0005-2442-0557
Zhi-Xiang LuRevvity Health Sciences, Revvity, Inc., Waltham, Massachusetts, USA.ORCID 0000-0001-9230-2169

Funding

Revvity, Inc.
6 · The paper itself

Abstract

Circular RNAs (circRNAs) have emerged as pivotal players in RNA therapeutics. Unlike linear counterparts, circRNAs possess a closed-loop structure, conferring them with enhanced stability and resistance to degradation. Ribozyme-based strategy stands out as the predominant method for synthetic circRNA production, by precisely cleaving and promoting the formation of a covalent circular structure. However, there is still a lack of analytical methods that can provide high-throughput and quantitative analysis to facilitate the circRNA vector engineering process. In the report, we detail analytical methods to characterize and evaluate ribozyme-based RNA circularization efficiency. Our approach will capture the attention of researchers interested in optimizing RNA circularization efficiency, as well as those focused on exploring key elements for ribozyme catalytic activity.

Indexed as

RNA, CatalyticRNA, CircularHumansRNARNARNA, CatalyticRNA, Circularcircular RNAlinear RNAmicrofluidic capillary electrophoresisvector engineering

Identifiers

PMID39345227
PMCPMC11662197

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.